Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ETHZilla Corp Director's Dealing 2020

Dec 2, 2020

33039_dirs_2020-12-01_c744d8f0-37d8-45e3-a255-2172eebd95fd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2020-11-17

Reporting Person: KRAUSS MARLENE (10% Owner)
Reporting Person: KBL IV SPONSOR LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-25 Common Stock S 12182 $2.7753 Disposed 2571556 Indirect
2020-11-23 Common Stock S 60633 $3.2602 Disposed 2583738 Indirect
2020-11-19 Common Stock S 33445 $2.118 Disposed 2644371 Indirect
2020-11-18 Common Stock S 6700 $2.3105 Disposed 2677816 Indirect
2020-11-17 Common Stock S 3300 $2.2562 Disposed 2684516 Indirect

Footnotes

F1: The shares are held directly by KBL Sponsor. Dr. Marlene Krauss, the former Chief Executive Officer, and a former memeber of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by KBL Sponsor in which she does not have a pecuniary interest.